LATEST NEWS

When a T cell makes up its mind to kill, it does not mess around.
Most vaccines include particles called adjuvants. But not all adjuvants are created equal.
New LJI research shows how a range of critical immune cells respond to SARS-CoV-2
The international recognition reflects how LJI research is valued by scientific peers
La Jolla Institute scientists team up with Brigham and Women's Hospital to guide the development of vaccines against the coronavirus family
Even elderly survivors show a strong, persistent immune memory
LJI-led Coronavirus Immunotherapeutic Consortium identifies antibody 'communities' with power to stop SARS-CoV-2 variants
Weiskopf reflects on nearly two years of non-stop COVID-19 research—and a recent honor from her native Austria
Immune system memory stays strong 6+ months post-vaccination, similar to responses in recovered COVID-19 patients
Local high school students bring art and science together for LJI’s Inaugural Art of the Immune System Competition
The CDC is reporting every severe breakthrough, but less is known about non-severe cases.